Greenwich LifeSciences, Inc. GLSI
18.70 USD +4.94 (+35.90%)
Regular-session close
18.70 0.00 0.00%
Pre-market · Nov 18, 8:07 AM ET
15.73 Day range 19.28
7.78 52-week range 34.10
- YTD
- -10.99%
- 1 year
- +127.22%
News
benzinga.com HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $70 HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $69 to $70.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release,…benzinga.com Greenwich Lifesciences To Present Two FLAMINGO-01 Trial Abstracts At SABCS 2026 Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated…
benzinga.com Greenwich LifeSciences Q3 EPS $(0.40) Misses $(0.30) Estimate Greenwich LifeSciences (NASDAQ:GLSI) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.30) by 33.33 percent. This is a 48.15 percent decrease over…
globenewswire.com Greenwich LifeSciences Announces Acceptance of Abstracts at SABCS 2026 STAFFORD, Texas, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,…
